RA Capital Management’s Post

F-Prime Capital is honored to once again co-host the #Science2Startup symposium, alongside others from the biotech investment community, to identify promising science and technologies with startup potential. F-Prime's Jessica Alston, Ph.D., will serve as an advisor for the event. "S2S is more than an event; It's a beacon for innovation where top scientists worldwide come together to present their ideas and interact with leading investors and executives in Boston's established biotech ecosystem," said Dr. Alston. "Our goal is to nurture our connections while supporting the translation of scientific breakthroughs to solve the greatest challenges in #healthcare and medicine." Learn more about this unique opportunity for scientists, entrepreneurs, #biotech operators, and investor to meet, collaborate and translate exciting ideas into real innovations: www.science2startup.com

BioSeed is exclusively designed for early-stage life sciences companies in pursuit of seed funding, so don't miss your chance to showcase your innovation on Monday 22 January in London 📣 This event provides a platform for these companies to engage with a diverse audience of active life sciences investors with quick-fire presentations, private pre-scheduled partnering meetings, and abundant networking opportunities throughout the day. You will also get extensive company promotion on social media, in OBN marketing emails, and on the BioSeed website leading up to and after the event. "Events like BioSeed are significant for supporting early stage innovation. There's the opportunity to present your company to a broad range of investors. And there's also the serendipity that comes from networking, when you might be talking to somebody who you might not think would be interested in your company but turns out to have some very good contacts and networks that you can leverage." Discovery Park Ventures Find out more and register here: https://lnkd.in/eBCqUtHn BioEscalator Start Codon Science Creates Discovery Park Rosalind Franklin Institute Lean Life Science King's College London UCL Oxford University Innovation Cambridge Innovation Capital #lifesciences #startup #biotech #medtech #networking

When it comes to 'tearing up the traditional biotech playbook' -- we are in the conversation. Nature published an article discussing how bigger and more expensive science requires more extensive collaboration and new funding opportunities. "... it is possible for startups to partner with core facilities at universities in the area to rent time on certain equipment, such as sequencers. One does not need to be in a big city to have this sort of arrangement. The Huck Institute at Pennsylvania State University, for example, runs 12 core labs and offers services for a fee to local companies." Read more about the future of research partnerships and how Penn State University is a great example: https://lnkd.in/gDdnaM83 Penn State Research Huck Institutes of the Life Sciences

Blue Forest Ventures is on a mission to redefine the landscape of scientific research by transforming innovative ideas into market-ready solutions. Did you know that nearly 90% of research initiatives never make it to the market? This staggering statistic highlights a significant gap between groundbreaking research and its potential real-world application. What sets Blue Forest apart is their approach to bridging this gap. By focusing on collaboration with scientists and entrepreneurs, they are not just funding projects; they are fostering an ecosystem where research can truly flourish and impact society. This proactive approach could potentially reshape industries and improve lives. As we look toward a future where research translates into tangible solutions, it’s clear that initiatives like these are vital for progress. What are your thoughts on the challenges researchers face in bringing their innovations to market, and how can companies better support this transition? https://lnkd.in/g8GSwbtE Startuprad.io

Exciting news! The 2024 Asia BioTech Conference is just around the corner, taking place from July 24-28 at the Nangang Exhibition Center. This year, we're expanding the forum by three times, featuring 900 exhibitors and over 2,200 booths—a record-breaking scale! Join us for one-on-one business matching with over 500 buyers, and explore cutting-edge innovations from renowned international biotech companies and investment institutions. Our conference will host three major forums: Innovation Technology, Investment Summit, and Regional Cooperation. Highlights include presentations from top biotech firms across the globe and discussions on groundbreaking topics such as AI in clinical trials, regenerative medicine, and precision health. Don’t miss this unparalleled opportunity to connect with industry leaders, gain insights into the latest biotech advancements, and explore investment prospects. Let's shape the future of biotechnology together! #AsiaBioTech2024 #Innovation #Investment #Biotechnology #Healthcare

📢 Are you a researcher in Switzerland and an aspiring entrepreneur with an idea for commercialization? Don't miss the opportunity of the bench2biz workshop in November 2024! Anyone from a Swiss academic or research institution with an idea in science and technology may apply, and the workshop is free of charge for selected applicants. Apply now to jump-start a new venture: https://lnkd.in/eAC8eZFy 📅 Dates: November 6, 13-19, 2024 (4 days online, 2 days in person at the University of Bern). Participants in the early phase of a technology application are helped to move to a concept stage, shape their venture ideas, determine the commercial value and marketability of their idea or invention, and set the groundwork for their business plan. Learn more about what we offer here: https://lnkd.in/e_GDRxiz   Organizers: NCCR RNA & Disease, NCCR Automation, NCCR Bio-Inspired Materials, Technology & Innovation Platform of NCCR PlanetS, NCCR Molecular Systems Engineering, NCCR SPIN: Spin Qubits in Silicon, NCCR AntiResist , and NCCR Microbiomes. With the support of Fonds national suisse FNS and Institut Fédéral de la Propriété Intellectuelle. #startups #innovation

Scientific research drives progress and innovation, often sparking the possibility to make a tangible impact on society. Yet, transitioning discoveries into viable ventures isn't without its challenges. From navigating the complexities of market applications to securing funding and engaging with potential investors, the journey from bench to bedside demands strategic navigation. Issues like identifying core applications, breaking through traditional norms, and securing resources are common. This is where Orchestra Life Sciences steps in. With our expertise in market analysis, strategic planning, and engineering solutions, we guide emerging biotech ventures to navigate these obstacles with confidence. By leveraging our insights and network, we help start-ups refine their focus, attract investors, and showcase their potential. #Biotech #ScientificEntrepreneurship #OLSExpertise

In tech transfer, crossing the "Valley of Death" means turning research into real-world applications. In his recent lecture at Michigan State University, Dr. DJ Nag highlights how strategic investments and partnerships can bridge the gap from research to market and transform groundbreaking research into viable products. Billions are invested annually in R&D in the U.S., yet the journey from an innovative idea to a marketable product is fraught with challenges. This gap—where potential and innovation fade or flourish—is where tech transfer specialists step in, supported by venture capital and government grants like SBIR. These resources can help navigate this valley and enable the move from patents and papers to products that impact lives. Are you facing challenges in tech transfer? How do you move from research to market in your field? _____ 🔁 Share this infographic with your network if you think it's useful. 🔔 Follow Innovaito, LLC for more intellectual property and technology transfer insights. #TechTransfer #InnovationManagement #RnD #StartupEcosystem #VentureCapital #Innovaito #IntellectualProperty #SBIR

All of us who have done #techtransfer know how important it is to bridge the chasm of the "valley of death". During my presentation to the students at the Michigan State University, we talked about the fundamentals of taking a technology to the market through: a) startups: Creating a new company around the technology b) traditional licensing: license a technology to an existing companies Unfortunately, more than 60% of academic patents are never licensed. We have been focused on this third mechanism of patent monetization. Performing the due diligence to find the valuable patents which are either: a) unlicensed b) non-exclusively licensed Often times, these unlicensed patents hold the key to bringing value to the overall licensing strategy. #artificialintelligence has truly changed the way patent due diligence is performed today. Using the right #AI tools we can triangulate on the most valuable patents in a portfolio. Thanks to my team for pulling together the old "valley of death" figure and giving it a fresh new look! Deyanira Borisova.

As we work to unveil the future of aging, we are thrilled to announce that we've been selected for the Yale Innovation Summit 2024 Virtual Showcase! Happening May 29th - 30th at the Yale University campus, we're excited to connect with leading investors, industry innovators, and fellow biotech pioneers at this premier event. Join us as we explore the future of longevity and share our mission to revolutionize the human experience. Interested in learning more about Eternity Biotech? Reach out to our team to schedule a meeting at the summit! In the meantime, let us know in the comments below what you're most looking forward to - see you there! #EternityBiotech #longevity #biotech #antiaging #YaleInnovationSummit #YaleInnovation24 #YaleVentures #innovation #entrepreneurship